Nolan Williams

AI Summary

→ WHAT IT COVERS Dr. Nolan Williams, Stanford neurologist-psychiatrist, explains how transcranial magnetic stimulation and psychedelics like psilocybin, MDMA, and ibogaine rewire depression and PTSD circuits. Both approaches target the same subgenual anterior cingulate-default mode network connection, producing remission in days without drugs remaining in the system. → KEY INSIGHTS - **Stanford Neuromodulation Therapy (SNT):** By applying TMS every hour for ten hours across five consecutive days, Williams' protocol delivers the equivalent of seven and a half months of standard TMS treatment. This spaced-learning approach produces full mood remission in 60–90% of patients within one to five days, with some maintaining remission for four or more years. - **MDMA for PTSD:** In clinical trials using 75–150mg MDMA administered one to two times under physician supervision, approximately two-thirds of PTSD patients achieved clinically significant symptom reduction. Effects lasted years in follow-up studies, compared to ketamine infusions, which average only ten days of relief per session before repeat dosing is required. - **Psilocybin for Depression:** Open-label psilocybin trials show 50–67% of patients achieving remission from depression; blinded controlled trials show roughly one-third responding. Both psilocybin and SNT produce the same measurable brain change: reduced connectivity between the negatively valenced subgenual anterior cingulate and the default mode network, suggesting a shared therapeutic mechanism. - **Circuit Model Replaces Chemical Imbalance:** Depression is not a serotonin deficit but a dysregulated prefrontal-cingulate circuit where the left dorsolateral prefrontal cortex fails to govern the conflict-detection system. TMS works by exogenously restoring that top-down regulation without altering serotonin, reframing depression as a correctable electrophysiological arrhythmia rather than a permanent chemical or psychological deficit. - **Ibogaine for Moral Injury and PTSD:** Ibogaine, extracted from African iboga root bark, produces a 24–36 hour closed-eye life-review experience that special operations veterans describe as enabling self-forgiveness for combat-related moral injury. Williams' ongoing first-in-human neurobiological study measures pre- and post-treatment depression scales, PTSD scales, neurocognitive batteries, neuroimaging, and EEG to quantify these effects systematically. → NOTABLE MOMENT Williams describes patients who achieve full remission mid-week during the five-day SNT protocol spontaneously reporting their first-ever experience of present-moment awareness — something they had read about in mindfulness literature but never accessed — without any instruction or suggestion from clinical staff beforehand. 💼 SPONSORS [{"name": "Function Health", "url": "https://functionhealth.com/huberman"}, {"name": "BetterHelp", "url": "https://betterhelp.com/huberman"}, {"name": "AG1", "url": "https://drinkag1.com/huberman"}] 🏷️ Transcranial Magnetic Stimulation, Psilocybin Therapy, PTSD Treatment, Depression Neuroscience, Ibogaine Research